Literature DB >> 20600472

High-frequency rTMS treatment increases left prefrontal myo-inositol in young patients with treatment-resistant depression.

Huirong Zheng1, Li Zhang, Lingjiang Li, Peng Liu, Junling Gao, Xiaoyun Liu, Juan Zou, Yan Zhang, Jun Liu, Zhijun Zhang, Zexuan Li, Weiwei Men.   

Abstract

BACKGROUND: Neuroimaging studies suggest that the prefrontal cortex (PFC) is involved in the pathophysiology of major depression. Repetitive transcranial magnetic stimulation (rTMS) as an antidepressant intervention has increasingly been investigated in the last two decades. In this study metabolic changes within PFC of severely depressed patients before and after rTMS were evaluated by proton magnetic resonance spectroscopy (1H-MRS).
METHOD: Thirty-four young depressed patients with treatment-resistant unipolar depression were enrolled in a double-blind, randomized study active ((n=19) vs. sham(n=15)), and the PFC was investigated before and after high-frequency (15 Hz) rTMS using 3-tesla proton magnetic resonance spectroscopy. Response was defined as a 50% reduction of the Hamilton depression rating scale. The results were compared with 28 age- and gender-matched healthy controls.
RESULTS: In depressive patients a significant reduction in myo-inositol (m-Ino) was observed pre-rTMS (p<0.001). After successful treatment, m-Ino increased significantly in left PFC and the levels no longer differed from those of age-matched controls. In addition to a positive correlation between clinical improvement and an increment in m-Ino ratio, a correlation between clinical improvement and early age onset was observed.
CONCLUSIONS: Our results support the notion that major depressive disorder is accompanied by state-dependent metabolic alterations, especially in myo-inositol metabolism, which can be partly reversed by successful rTMS.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600472     DOI: 10.1016/j.pnpbp.2010.06.009

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  15 in total

1.  Evaluation of Myo-Inositol as a Potential Biomarker for Depression in Schizophrenia.

Authors:  Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Florian Muellerklein; Malle Tagamets; Robert P McMahon; Frank Gaston; Peter Kochunov; L Elliot Hong
Journal:  Neuropsychopharmacology       Date:  2015-02-27       Impact factor: 7.853

2.  Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis.

Authors:  Laura E Leggett; Lesley J J Soril; Stephanie Coward; Diane L Lorenzetti; Gail MacKean; Fiona M Clement
Journal:  Prim Care Companion CNS Disord       Date:  2015-11-05

3.  NAA/Glu Ratio Associated with Suicidal Ideation in Pilot Sample of Autistic Youth and Young Adults.

Authors:  Iska Moxon-Emre; Paul E Croarkin; Zafiris J Daskalakis; Daniel M Blumberger; Rachael E Lyon; Hideaki Tani; Peter Truong; Meng-Chuan Lai; Pushpal Desarkar; Napapon Sailasuta; Peter Szatmari; Stephanie H Ameis
Journal:  Brain Sci       Date:  2022-06-15

4.  Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.

Authors:  Paul E Croarkin; Paul A Nakonezny; Christopher A Wall; Lauren L Murphy; Shirlene M Sampson; Mark A Frye; John D Port
Journal:  Psychiatry Res Neuroimaging       Date:  2015-11-27       Impact factor: 2.376

5.  Variations in myo-inositol in fronto-limbic regions and clinical response to electroconvulsive therapy in major depression.

Authors:  Stephanie Njau; Shantanu H Joshi; Amber M Leaver; Megha Vasavada; Jessica Van Fleet; Randall Espinoza; Katherine L Narr
Journal:  J Psychiatr Res       Date:  2016-05-28       Impact factor: 4.791

Review 6.  Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review.

Authors:  Thiago M Fidalgo; J Leon Morales-Quezada; Guilherme S C Muzy; Noelle M Chiavetta; Mariana E Mendonca; Marcus V B Santana; Oscar F Goncalves; Andre R Brunoni; Felipe Fregni
Journal:  J ECT       Date:  2014-03       Impact factor: 3.635

7.  Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-05-06

8.  More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997-2013.

Authors:  Karina Karolina Kedzior; Valeriya Azorina; Sarah Kim Reitz
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-07       Impact factor: 2.570

9.  Prenatal stress and peripubertal stimulation of the endocannabinoid system differentially regulate emotional responses and brain metabolism in mice.

Authors:  Simone Macrì; Chiara Ceci; Rossella Canese; Giovanni Laviola
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Abnormalities of cortical-limbic-cerebellar white matter networks may contribute to treatment-resistant depression: a diffusion tensor imaging study.

Authors:  Hong-jun Peng; Hui-rong Zheng; Yu-ping Ning; Yan Zhang; Bao-ci Shan; Li Zhang; Hai-chen Yang; Jun Liu; Ze-xuan Li; Jian-song Zhou; Zhi-jun Zhang; Ling-jiang Li
Journal:  BMC Psychiatry       Date:  2013-03-02       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.